Literature DB >> 24291058

Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction.

Christoph Liebetrau1, Luise Gaede2, Oliver Dörr3, Christian Troidl2, Sandra Voss2, Jedrzej Hoffmann2, Agata Paszko2, Michael Weber2, Andreas Rolf2, Christian Hamm4, Holger Nef3, Helge Möllmann2.   

Abstract

BACKGROUND: N-terminal segment of B-type natriuretic peptide prohormone (NT-proBNP) is elevated in patients with acute myocardial infarction (AMI) thus providing both diagnostic information and prognostic information. The aim of the present study was to determine the time course of NT-proBNP release in patients undergoing transcoronary ablation of septal hypertrophy (TASH) a procedure mimicking AMI.
METHODS: We analyzed the release kinetics of NT-proBNP in 18 consecutive patients with hypertrophic obstructive cardiomyopathy undergoing TASH. Serum samples were collected prior to and at 15, 30, 45, 60, 75, 90, and 105 min, and 2, 4, 8, and 24h after TASH.
RESULTS: NT-proBNP concentrations showed a continuous increase during the first 75 min with a significant percent change compared to baseline value already 15 min after TASH (105.6% [IQR 102.2-112.7]; P<0.001). All patients had a significant increase of NT-proBNP at 45 min (range of percent increase [min-max]: 103.5-137.2%; range of absolute increase [min-max]: 23.5-304.0 ng/L). NT-proBNP concentrations decreased below the baseline value until the 8th h after initiation of myocardial infarction.
CONCLUSION: NT-proBNP concentration increases immediately after induction of myocardial infarction proving early evidence of myocardial injury despite the decrease of the left ventricular wall stress due to the TASH related reduction of the left ventricular outflow gradient.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  N-terminal pro-B-type natriuretic peptide; Release kinetics; Transcoronary ablation of septal hypertrophy

Mesh:

Substances:

Year:  2013        PMID: 24291058     DOI: 10.1016/j.cca.2013.11.017

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Neprilysin levels at the acute phase of ST-elevation myocardial infarction.

Authors:  Hugo Bernelin; Nathan Mewton; Salim Si-Mohamed; Pierre Croisille; Gilles Rioufol; Eric Bonnefoy-Cudraz; Philippe Douek; Nathalie Dufay; Camille Amaz; Claire Jossan; Michel Ovize; Thomas Bochaton
Journal:  Clin Cardiol       Date:  2018-12-10       Impact factor: 2.882

2.  Cardiac Myosin Binding Protein-C Autoantibodies are Potential Early Indicators of Cardiac Dysfunction and Patient Outcome in Acute Coronary Syndrome.

Authors:  Thomas L Lynch; Diederik W D Kuster; Beverly Gonzalez; Neelam Balasubramanian; Nandini Nair; Sharlene Day; Jenna E Calvino; Yanli Tan; Christoph Liebetrau; Christian Troidl; Christian W Hamm; Ahmet Güçlü; Barbara McDonough; Ali J Marian; Jolanda van der Velden; Christine E Seidman; Gordon S Huggins; Sakthivel Sadayappan
Journal:  JACC Basic Transl Sci       Date:  2016-12-19

3.  Dynamics of high-sensitivity cardiac troponin T during therapy with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Steffen D Kriechbaum; Christoph B Wiedenroth; Till Keller; Jan Sebastian Wolter; Ruth Ajnwojner; Karina Peters; Moritz A Haas; Fritz C Roller; Andreas Breithecker; Andreas J Rieth; Stefan Guth; Andreas Rolf; Dirk Bandorski; Christian W Hamm; Eckhard Mayer; Christoph Liebetrau
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

4.  Efficacy and safety of traditional Chinese medicine injections in the treatment of acute myocardial infarction: A protocol for systematic review and network meta-analysis.

Authors:  Wei Zhao; Jun Li; Hengwen Chen; Qingjuan Wu; Yawen Deng; Yuqing Tan
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.